ARDELYX, INC. Revenues
ARDELYX, INC. (ARDX) reported Revenues of $3.01 million for the 3-month period ending 2019-09-30, per its 10-Q filed 2019-11-06.
Discontinued › Income Statement
us-gaap:Revenues · last filed 2019-11-06
- ARDELYX, INC. revenues for the quarter ending 2019-09-30 was $3.01M, a 1651.74% increase year-over-year.
- ARDELYX, INC. revenues for the quarter ending 2019-06-30 was $18.00K, a 40.00% decline year-over-year.
- ARDELYX, INC. revenues for the quarter ending 2018-12-31 was $85.00K, a 99.80% decline year-over-year.
- ARDELYX, INC. revenues for the quarter ending 2018-09-30 was $172.00K.
- ARDELYX, INC. revenues for fiscal 2018 was $2.61M, a 93.79% decline from fiscal 2017.
- ARDELYX, INC. revenues for fiscal 2017 was $42.00M.
- ARDELYX, INC. revenues for fiscal 2015 was $24.03M, a 24.02% decline from fiscal 2014.
- ARDELYX, INC. revenues for fiscal 2014 was $31.62M, a 9.32% increase from fiscal 2013.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2019-09-30 | $3.01M 10-Q · filed 2019-11-06 | $3.03M derived: sum of 2 quarters · filed 2019-11-06 | $3.03M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $18.00K 10-Q · filed 2019-08-09 | $18.00K 10-Q · filed 2019-08-09 | ||
| 2018-12-31 | $85.00K 10-K · filed 2019-03-06 | $257.00K derived: sum of 2 quarters · filed 2019-11-06 | $287.00K derived: sum of 3 quarters · filed 2019-11-06 | $2.61M 10-K · filed 2019-03-06 |
| 2018-09-30 | $172.00K 10-Q · filed 2019-11-06 | $202.00K derived: sum of 2 quarters · filed 2019-11-06 | $2.52M 10-Q · filed 2019-11-06 | $44.52M derived: sum of 4 quarters · filed 2019-11-06 |
| 2018-06-30 | $30.00K 10-Q · filed 2019-08-09 | $2.35M 10-Q · filed 2019-08-09 | $44.35M derived: sum of 3 quarters · filed 2019-08-09 | |
| 2018-03-31 | $2.32M 10-K · filed 2019-03-06 | $44.32M derived: sum of 2 quarters · filed 2019-03-06 | ||
| 2017-12-31 | $42.00M 10-K · filed 2019-03-06 | $42.00M 10-K · filed 2019-03-06 | ||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $0.00 derived: sum of 2 quarters · filed 2018-03-14 | $18.14M derived: sum of 3 quarters · filed 2018-03-14 | $24.03M 10-K · filed 2018-03-14 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $18.14M derived: sum of 2 quarters · filed 2017-02-17 | $24.03M 10-Q · filed 2016-11-07 | $30.36M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-06-30 | $18.14M 10-K · filed 2017-02-17 | $24.03M 10-Q · filed 2016-08-08 | $30.36M derived: sum of 3 quarters · filed 2017-02-17 | $37.96M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-03-31 | $5.88M 10-K · filed 2017-02-17 | $12.22M derived: sum of 2 quarters · filed 2017-02-17 | $19.82M derived: sum of 3 quarters · filed 2017-02-17 | $28.96M derived: sum of 4 quarters · filed 2017-02-17 |
| 2014-12-31 | $6.34M 10-K · filed 2016-03-04 | $13.94M derived: sum of 2 quarters · filed 2016-03-04 | $23.07M derived: sum of 3 quarters · filed 2016-03-04 | $31.62M 10-K · filed 2017-02-17 |
| 2014-09-30 | $7.60M 10-K · filed 2016-03-04 | $16.73M derived: sum of 2 quarters · filed 2016-03-04 | $25.28M 10-Q · filed 2015-11-12 | $33.77M derived: sum of 4 quarters · filed 2016-03-04 |
| 2014-06-30 | $9.14M 10-K · filed 2016-03-04 | $17.69M 10-Q · filed 2015-08-12 | $26.18M derived: sum of 3 quarters · filed 2016-03-04 | $32.77M derived: sum of 4 quarters · filed 2016-03-04 |
| 2014-03-31 | $8.55M 10-K · filed 2016-03-04 | $17.04M derived: sum of 2 quarters · filed 2016-03-04 | $23.63M derived: sum of 3 quarters · filed 2016-03-04 | $30.92M derived: sum of 4 quarters · filed 2016-03-04 |
| 2013-12-31 | $8.49M 10-K · filed 2015-03-05 | $15.08M derived: sum of 2 quarters · filed 2015-03-05 | $22.37M derived: sum of 3 quarters · filed 2015-03-05 | $28.93M 10-K · filed 2016-03-04 |
| 2013-09-30 | $6.59M 10-K · filed 2015-03-05 | $13.88M derived: sum of 2 quarters · filed 2015-03-05 | $20.44M 10-Q · filed 2014-11-07 | |
| 2013-06-30 | $7.29M 10-K · filed 2015-03-05 | $13.85M 10-Q · filed 2014-08-08 | ||
| 2013-03-31 | $6.56M 10-K · filed 2015-03-05 | |||
| 2012-12-31 | $5.41M 10-K · filed 2015-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |